Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.

PHILADELPHIA, PA / ACCESSWIRE / September 30, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, JEQ, THQ)(NYSE American:IAF), (the "Funds" or ...

Despite these claims, Gunn took to Threads to deny the rumor that Pyg and Scarecrow will join Hush, Clayface, and Robin in Part 2. However, this statement implies the latter three characters will ...

Counting down the Top 30 most-voted-for and crowns Your Ultimate Great British Group.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

(NASDAQ: IMNN) (the “Company”), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced that the Compensation Committee of the Company’s Board of ...

As noted above, stellate cell activation is the central event in hepatic fibrosis. Activation consists of 2 major phases: (1) initiation (also called apreinflammatory stage) and (2) perpetuation ...

2, 2024 — A new pathway that is used by cancer ... 12, 2024 — Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against ...

Crohn's disease and ulcerative colitis are idiopathic, chronic, relapsing, inflammatory conditions that are immunologically mediated. Although their exact etiologies remain uncertain, results from ...